Betty Zhang1, Zainab Najarali1,2, Leyo Ruo3,4, Abdullah Alhusaini5, Natalie Solis4, Marlie Valencia4, Maria Ines Pinto Sanchez6, Pablo E Serrano7,8. 1. Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada. 2. Department of Postgraduate Medical Education, University of Toronto, Toronto, ON, Canada. 3. Department of Oncology, McMaster University, Hamilton, ON, Canada. 4. Department of Surgery, McMaster University, Hamilton, ON, Canada. 5. Royal College of Surgeons in Ireland, Dublin, Ireland. 6. Department of Medicine, Division of Gastroenterology, McMaster University, Hamilton, ON, Canada. 7. Department of Surgery, McMaster University, Hamilton, ON, Canada. serrano@mcmaster.ca. 8. Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada. serrano@mcmaster.ca.
Abstract
BACKGROUND: Perioperative carbohydrate loading, increased protein intake, and immunonutrition may decrease postoperative complications. Studies on the topic have led to controversial results. METHODS: We searched Medline, EMBASE, and CENTRAL up to August 2018 for randomized trials comparing the effect of perioperative nutritional supplements (intervention) versus control on postoperative complications in patients undergoing gastrointestinal cancer surgery. Secondary outcomes included infectious complications and length of hospital stay (LOS). Random effects model was used to estimate the pooled risk ratio (RR) of treatment effects. Pooled mean difference (MD) was used to compare LOS. Heterogeneity was assessed using I2. Sources of heterogeneity were explored through subgroup analysis by nutritional supplementation protocol, type of surgery, and type of nutritional supplement. Risk of bias and quality of the evidence were assessed. RESULTS: Of 3951 articles, we identified 56 trials (n = 6370). Perioperative nutrition was associated with a lower risk of postoperative complications (RR 0.74, 95% confidence interval (CI) 0.69-0.80); postoperative infections (RR 0.71, 95% CI 0.64-0.79, n = 4582); and postoperative non-infectious complications (RR 0.79, 95% CI 0.71-0.87, n = 4883). There were no significant heterogeneity outcomes analyzed (I2 = 14%, 1%, and 7%, respectively). LOS was shorter for the intervention group, MD - 1.58 days; 95% CI - 1.83 to - 1.32; I2 = 89%). Subgroup analysis did not identify sources of heterogeneity. The quality of evidence for postoperative complications was high and for LOS was moderate. CONCLUSION: Perioperative nutritional optimization decreases the risk of postoperative infectious and non-infectious complications. It also decreases LOS in patients undergoing gastrointestinal cancer surgery, but these findings should be taken with caution given the high heterogeneity.
BACKGROUND: Perioperative carbohydrate loading, increased protein intake, and immunonutrition may decrease postoperative complications. Studies on the topic have led to controversial results. METHODS: We searched Medline, EMBASE, and CENTRAL up to August 2018 for randomized trials comparing the effect of perioperative nutritional supplements (intervention) versus control on postoperative complications in patients undergoing gastrointestinal cancer surgery. Secondary outcomes included infectious complications and length of hospital stay (LOS). Random effects model was used to estimate the pooled risk ratio (RR) of treatment effects. Pooled mean difference (MD) was used to compare LOS. Heterogeneity was assessed using I2. Sources of heterogeneity were explored through subgroup analysis by nutritional supplementation protocol, type of surgery, and type of nutritional supplement. Risk of bias and quality of the evidence were assessed. RESULTS: Of 3951 articles, we identified 56 trials (n = 6370). Perioperative nutrition was associated with a lower risk of postoperative complications (RR 0.74, 95% confidence interval (CI) 0.69-0.80); postoperative infections (RR 0.71, 95% CI 0.64-0.79, n = 4582); and postoperative non-infectious complications (RR 0.79, 95% CI 0.71-0.87, n = 4883). There were no significant heterogeneity outcomes analyzed (I2 = 14%, 1%, and 7%, respectively). LOS was shorter for the intervention group, MD - 1.58 days; 95% CI - 1.83 to - 1.32; I2 = 89%). Subgroup analysis did not identify sources of heterogeneity. The quality of evidence for postoperative complications was high and for LOS was moderate. CONCLUSION: Perioperative nutritional optimization decreases the risk of postoperative infectious and non-infectious complications. It also decreases LOS in patients undergoing gastrointestinal cancer surgery, but these findings should be taken with caution given the high heterogeneity.
Authors: L Gianotti; M Braga; C Fortis; L Soldini; A Vignali; S Colombo; G Radaelli; V Di Carlo Journal: JPEN J Parenter Enteral Nutr Date: 1999 Nov-Dec Impact factor: 4.016
Authors: Antonio Jesús Martínez-Ortega; Ana Piñar-Gutiérrez; Pilar Serrano-Aguayo; Irene González-Navarro; Pablo Jesús Remón-Ruíz; José Luís Pereira-Cunill; Pedro Pablo García-Luna Journal: Nutrients Date: 2022-04-12 Impact factor: 6.706
Authors: Manfredi Tesauro; Andrea M Guida; Leandro Siragusa; Bruno Sensi; Vittoria Bellato; Nicola Di Daniele; Andrea Divizia; Marzia Franceschilli; Giuseppe S Sica Journal: J Clin Med Date: 2021-01-22 Impact factor: 4.241
Authors: Alba Fernández-Candela; Alicia Calero; Luís Sánchez-Guillén; Javier Escrig-Sos; José A Barreras; Francisco López-Rodríguez-Arias; Laura Armañanzas; Ana Murcia; Antonio Arroyo; Francisco Javier Lacueva Journal: Nutrients Date: 2021-06-23 Impact factor: 5.717